Summit Corp Loss Widens As Drug Programmes Progress
LONDON (Alliance News) - Drug company Summit Corporation PLC Wednesday said its loss widened in its last financial year as its research and development costs rose as both its drug programmes moved towards clinical trials. The Oxford-based company is currently developing treatments for Duche
Read more